Association of Derived Neutrophil-To-Lymphocyte Ratio With Prognosis of Coronary Heart Disease After PCI

被引:6
|
作者
Liu, Gang-Qiong [1 ]
Zhang, Wen-Jing [1 ]
Shangguan, Jia-Hong
Zhu, Xiao-Dan
Wang, Wei [2 ]
Guo, Qian-Qian [1 ]
Zhang, Jian-Chao [1 ]
Wang, Kai [1 ]
Liu, Zhi-Yu [1 ]
Song, Feng-Hua [1 ]
Fan, Lei [1 ]
Zheng, Ying-Ying [1 ]
Zhang, Jin-Ying [1 ]
机构
[1] Zhengzhou Univ, Dept Cardiol, Key Lab Cardiac Injury & Repair Henan Prov, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Henan Med Assoc, Adm Dept, Zhengzhou, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2021年 / 8卷
基金
中国国家自然科学基金;
关键词
derived neutrophil-to-lymphocyte ratio; percutaneous coronary intervention; mortality; neutrophil-to-lymphocyte ratio; coronary heart disease; PREDICTIVE-VALUE; RISK; ATHEROSCLEROSIS; REDISTRIBUTION; INFLAMMATION; MONOCYTE; CANCER; COUNT;
D O I
10.3389/fcvm.2021.705862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: The present study aimed to investigate the prognostic role of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with coronary heart disease (CHD) after PCI. Methods: A total of 3,561 post-PCI patients with CHD were retrospectively enrolled in the CORFCHD-ZZ study from January 2013 to December 2017. The patients (3,462) were divided into three groups according to dNLR tertiles: the first tertile (dNLR < 1.36; n = 1,139), second tertile (1.36 >= dNLR < 1.96; n = 1,166), and third tertile(dNLR >= 1.96; n = 1,157). The mean follow-up time was 37.59 +/- 22.24 months. The primary endpoint was defined as mortality (including all-cause death and cardiac death), and the secondary endpoint was major adverse cardiovascular events (MACEs) and major adverse cardiovascular and cerebrovascular events (MACCEs). Results: There were 2,644 patients with acute coronary syndrome (ACS) and 838 patients with chronic coronary syndrome (CCS) in the present study. In the total population, the all-cause mortality (ACM) and cardiac mortality (CM) incidence was significantly higher in the third tertile than in the first tertile [hazard risk (HR) = 1.8 (95% CI: 1.2-2.8), p = 0.006 and HR = 2.1 (95% CI: 1.23-3.8), p = 0.009, respectively]. Multivariate Cox regression analyses suggested that compared with the patients in the first tertile than those in the third tertile, the risk of ACM was increased 1.763 times (HR = 1.763, 95% CI: 1.133-2.743, p = 0.012), and the risk of CM was increased 1.763 times (HR = 1.961, 95% CI: 1.083-3.550, p = 0.026) in the higher dNLR group during the long-term follow-up. In both ACS patients and CCS patients, there were significant differences among the three groups in the incidence of ACM in univariate analysis. We also found that the incidence of CM was significantly different among the three groups in CCS patients in both univariate analysis (HR = 3.541, 95% CI: 1.154-10.863, p = 0.027) and multivariate analysis (HR = 3.136, 95% CI: 1.015-9.690, p = 0.047). Conclusion: The present study suggested that dNLR is an independent and novel predictor of mortality in CHD patients who underwent PCI.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] The Association of Nonalcoholic Fatty Liver Disease With Neutrophil-to-Lymphocyte Ratio and Neutrophil-Percentage-to-Albumin Ratio
    Cucoranu, Dragos Constantin
    Pop, Marian
    Niculescu, Raluca
    Kosovski, Irina-Bianca
    Toganel, Radu-Ovidiu
    Licu, Razvan-Andrei
    Bacarea, Anca
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [22] The neutrophil-to-lymphocyte ratio is associated with coronary heart disease risk in adults: A population-based study
    Wang, Yu
    Zhuang, Yangping
    Lin, Changsha
    Hong, Hanqing
    Chen, Feng
    Ke, Jun
    PLOS ONE, 2024, 19 (02):
  • [23] Interaction of Uric Acid and Neutrophil-to-Lymphocyte Ratio for Cardiometabolic Risk Stratification and Prognosis in Coronary Artery Disease Patients
    Del Turco, Serena
    Bastiani, Luca
    Minichilli, Fabrizio
    Landi, Patrizia
    Basta, Giuseppina
    Pingitore, Alessandro
    Vassalle, Cristina
    ANTIOXIDANTS, 2022, 11 (11)
  • [24] The correlation of systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, derived neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with disease severity in recurrent aphthous stomatitis
    Tanacan, Efsun
    Rota, Didem Dincer
    Oktem, Rumeysa
    Erdogan, Fatma Gulru
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (10) : 4858 - 4863
  • [25] Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Heart Failure Reply
    Durmus, Erdal
    Kivrak, Tarik
    Gerin, Fethullah
    Sunbul, Murat
    Sari, Ibrahim
    Erdogan, Okan
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2016, 106 (03) : 266 - 266
  • [26] Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure
    Durmus, Erdal
    Kivrak, Tarik
    Gerin, Fethullah
    Sunbul, Murat
    Sari, Ibrahim
    Erdogan, Okan
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2015, 105 (06) : 606 - 612
  • [27] Association of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with coronary artery disease severity
    Ramezani, Javad
    Kalat, Hamidreza Bagherian
    Hashemian, Amir Masoud
    Mehramiz, Neema John
    Foroughian, Mandi
    MEDICAL SCIENCE, 2019, 23 (96) : 211 - 216
  • [28] Neutrophil to lymphocyte ratio is associated with the severity of coronary heart disease
    Pfeffer, M.
    Fiedler, L.
    Schoenbauer, R.
    Egger, F.
    Culinovic, T.
    Haiden, A.
    Haumer, M.
    Roithinger, F. X.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : S59 - S59
  • [29] Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease
    Verdoia, M.
    Schaffer, A.
    Barbieri, L.
    Aimaretti, G.
    Marino, P.
    Sinigaglia, F.
    Suryapranata, H.
    De Luca, G.
    DIABETES & METABOLISM, 2015, 41 (04) : 304 - 311
  • [30] The Neutrophil-to-Lymphocyte Ratio Is Valuable at All Stages of Coronary Artery Disease Reply
    Ipek, Gokturk
    Onuk, Tolga
    Karatas, Mehmet Baran
    Gungor, Baris
    Atasoy, Isil
    Murat, Ahmet
    Aldag, Mustafa
    Yelgec, Nizamettin Selcuk
    Dayi, Sennur Unal
    Bolca, Osman
    CARDIOLOGY, 2015, 133 (01) : 57 - 57